# Bioequivalence Study Comparing Two Formulations of Escitalopram

> **NCT01395433** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Escitalopram
- **DRUG:** Escitalopram
- **DRUG:** Escitalopram

## Key facts

- **NCT ID:** NCT01395433
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-03
- **Final completion:** —
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2012-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01395433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01395433, "Bioequivalence Study Comparing Two Formulations of Escitalopram". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01395433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*